Strategies for targeting cytokines in inflammatory bowel disease
Crossref DOI link: https://doi.org/10.1038/s41577-024-01008-6
Published Online: 2024-03-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Neurath, Markus F.
Text and Data Mining valid from 2024-03-14
Version of Record valid from 2024-03-14
Article History
Accepted: 9 February 2024
First Online: 14 March 2024
Competing interests
: M.F.N. has served as an adviser for Abbvie, Janssen, Boehringer, MSD, UCB, PPM, Pentax and Takeda.